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Summary
A pivotal regulator of cell polarity and homeostasis, partitioning-defective protein 6 (Par6) forms multicomponent complexes that not only regulate cell polarity and stabilize cell morphology, but have also been demonstrated to participate in the proliferation, migration and invasion of cancer cells. The transforming growth factor (TGF)-β and extracellular signal-regulated kinase (Erk) 1/2 pathways are the most thoroughly studied pathways involving Par6 in many cancers. Aurothiomalate has been used to disrupt the interaction between Par6 and atypical protein kinase C within the multicomponent complexes, and has been shown to effectively block transformed growth and metastasis in vitro and/or in vivo in a variety of cancers, including pancreatic, prostate and lung cancers, as well as alveolar rhabdomyosarcoma. It is likely that with further revelations regarding the critical roles of Par6 in cancer initiation, progression and metastasis, targeted therapies against Par6 will be discovered and prove effective preclinically, and hopefully clinically, in cancer treatment.
K E Y W O R D S
cancer, cell polarization, epithelial-mesenchymal transition, partitioning-defective protein 6, transforming growth factor beta
| INTRODUCTION
Cell polarity, defined as the asymmetric organization of the cytoskeleton, cellular plasma membrane and organelles, is a fundamental feature of eukaryotic cells and is implicated in differentiation, proliferation and morphogenesis. Evidence has shown that precisely controlled cell polarization plays crucial roles in physiology and tissue homeostasis of normal cells, and deregulation of cell polarity has been implicated in tumorigenesis and tumour progression (for reviews, see Aranda et al., ). More specifically, as an important protein family involved in the regulation of cellular polarity, partitioning-defective protein 6 (Par6) has been demonstrated to participate in cancer initiation, progression and metastasis.
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The Par6 family was first identified in a milestone genetic screen to discover genes important for asymmetric embryonic cell division in
Caenorhabditis elegans. 5 Members of the Par6 family are ubiquitously 
| PAR6 AND ITS COMPLEXES IN TUMOURS
In addition to its pivotal roles in regulating cell polarity, Par6 has recently been identified as an important signalling hub in tumorigenesis and cancer development. 14 Another study showed that the interaction between Par6 and aPKC is required to protect cells from apoptotic death during the development of carcinoma.
15
Cell migration and invasion are essentially polarized processes.
Metastasesare the cause of 90% of human cancer deaths. 16 So, controlling the migration and invasion of cancer cells is one of the primary tasks in cancer treatment. Several studies have shown that Par6 plays essential roles in the regulation of cell migration and invasion.
For example, Par6 has been shown to promote degradation of Ras homolog gene family, member A (RhoA) with SMAD-specific E3 ubiquitin protein ligase 1 (Smurf1) and participate in establishing front and rear polarity. Furthermore, this interaction was required to maintain the motility of tumour cells. 17 Sahai et al. 18 reported that depletion of Par6, Par3, discoidin domain receptor tyrosine kinase 1 (DDR1) or Ras homolog gene family, member E (RhoE) led to defective collective cancer cell invasion and a loss of cell-cell cohesion.
| Breast cancer
Using mouse breast cancer cell lines, Viloria-Petit et al. 19 revealed that phosphorylation of Par6 on Ser 345 by transforming growth factor (TGF)-β receptor 1 (TGFBR1) mediates TGF-β-induced EMT of breast cancer cells by disrupting regular epithelial polarity and organization. 19 The results from additional studies 17, [20] [21] [22] suggested that activated Par6 complexes mediate dissolution of TJs during EMT by recruiting Smurf1, which, in turn, leads to ubiquitin-dependent degradation of RhoA. Nolan et al. 
| Prostate cancer
Mu et al. 28 found that TGF-β phosphorylated Par6 at Ser 345 and in- 
| CONSISTENCIES AND INCONSISTENCIES IN SIGNALLING PATHWAYS

| Transforming growth factor-β-Par6 pathway
To date, the TGF-β-Par6 pathway is the most intensively and thoroughly studied signalling pathway involving Par6 in various cancers. 
| Inconsistencies in study findings
There are also some inconsistencies in the reported research on Par6.
Although previous studies have shown that activated TGF-β-Par6 signalling can promote the migration and EMT of cancer cells, 19, 24, 28 a recent study reported that Par6 activation is necessary for TGF-β-induced apoptosis in normal murine mammary gland cells. 
| CONCLUSIONS AND PERSPECTIVES
In summary, as an important protein family with a role in maintaining normal cell homeostasis and regulating cell polarity, there is increasing evidence that Par6 also plays critical roles in oncogenesis and cancer 
